메뉴 건너뛰기




Volumn 44, Issue 5, 2014, Pages 839-843

Polymorphisms in MMP-2 and TIMP-2 in Turkish patients with prostate cancer

Author keywords

Matrix metalloproteinases; Polymorphism; Prostate cancer; Tissue inhibitors of metalloproteinases

Indexed keywords

GELATINASE A; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

EID: 84905659763     PISSN: 13000144     EISSN: None     Source Type: Journal    
DOI: 10.3906/sag-1305-63     Document Type: Article
Times cited : (25)

References (31)
  • 2
    • 79957812413 scopus 로고    scopus 로고
    • Association of short tandem repeat polymorphism in the promoter of prostate cancer antigen 3 gene with the risk of prostate cancer
    • Zhou W, Chen Z, Hu W, Shen M, Zhang X, Li C, Wen Z, Wu X, Hu Y, Zhang X et al. Association of short tandem repeat polymorphism in the promoter of prostate cancer antigen 3 gene with the risk of prostate cancer. PLoS One 2011; 6: e20378.
    • (2011) PLoS One , vol.6 , pp. 20378
    • Zhou, W.1    Chen, Z.2    Hu, W.3    Shen, M.4    Zhang, X.5    Li, C.6    Wen, Z.7    Wu, X.8    Hu, Y.9    Zhang, X.10
  • 3
    • 36049005089 scopus 로고    scopus 로고
    • Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation
    • Van Lint P, Libert C. Chemokine and cytokine processing by matrix metalloproteinases and its effect on leukocyte migration and inflammation. J Leukoc Biol 2007; 82: 1375-81.
    • (2007) J Leukoc Biol , vol.82 , pp. 1375-1381
    • van Lint, P.1    Libert, C.2
  • 4
    • 36849080314 scopus 로고    scopus 로고
    • Matrix metalloproteinases at cancer tumor-host interface
    • Noel A, Jost M, Maquoi E. Matrix metalloproteinases at cancer tumor-host interface. Semin Cell Dev Biol 2008; 19: 52-60.
    • (2008) Semin Cell Dev Biol , vol.19 , pp. 52-60
    • Noel, A.1    Jost, M.2    Maquoi, E.3
  • 5
    • 31344458952 scopus 로고    scopus 로고
    • Structure and function of matrix metalloproteinases and TIMPs
    • Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc Res 2006; 69: 562-73.
    • (2006) Cardiovasc Res , vol.69 , pp. 562-573
    • Nagase, H.1    Visse, R.2    Murphy, G.3
  • 6
    • 38549125513 scopus 로고    scopus 로고
    • The tumor microenvironment: Regulation by MMP-independent effects of tissue inhibitor of metalloproteinases-2
    • Stetler-Stevenson WG. The tumor microenvironment: regulation by MMP-independent effects of tissue inhibitor of metalloproteinases-2. Cancer Metastasis Rev 2008; 27: 57-66.
    • (2008) Cancer Metastasis Rev , vol.27 , pp. 57-66
    • Stetler-Stevenson, W.G.1
  • 9
    • 0036512208 scopus 로고    scopus 로고
    • New functions for the matrix metalloproteinases in cancer progression
    • Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002; 2: 161-74.
    • (2002) Nat Rev Cancer , vol.2 , pp. 161-174
    • Egeblad, M.1    Werb, Z.2
  • 10
    • 77956301181 scopus 로고    scopus 로고
    • Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion
    • Bourboulia D, Stetler-Stevenson WG. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): positive and negative regulators in tumor cell adhesion. Semin Cancer Biol 2010; 20: 161-8.
    • (2010) Semin Cancer Biol , vol.20 , pp. 161-168
    • Bourboulia, D.1    Stetler-Stevenson, W.G.2
  • 11
    • 15244348390 scopus 로고    scopus 로고
    • Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers
    • Turpeenniemi-Hujanen T. Gelatinases (MMP-2 and -9) and their natural inhibitors as prognostic indicators in solid cancers. Biochimie 2005; 87: 287-97.
    • (2005) Biochimie , vol.87 , pp. 287-297
    • Turpeenniemi-Hujanen, T.1
  • 14
    • 5044228029 scopus 로고    scopus 로고
    • Genetic predisposition to cancer - insights from population genetics
    • Frank SA. Genetic predisposition to cancer - insights from population genetics. Nat Rev Genet 2004; 5: 764-72.
    • (2004) Nat Rev Genet , vol.5 , pp. 764-772
    • Frank, S.A.1
  • 15
    • 84859005156 scopus 로고    scopus 로고
    • Prostate cancer genomics, biology, and risk assessment through genome-wide association studies
    • Nakagawa H, Akamatsu S, Takata R, Takahashi A, Kubo M, Nakamura Y. Prostate cancer genomics, biology, and risk assessment through genome-wide association studies. Cancer Sci 2012; 103: 607-13.
    • (2012) Cancer Sci , vol.103 , pp. 607-613
    • Nakagawa, H.1    Akamatsu, S.2    Takata, R.3    Takahashi, A.4    Kubo, M.5    Nakamura, Y.6
  • 16
    • 84855862051 scopus 로고    scopus 로고
    • The role of EZH2 in the regulation of the activity of matrix metalloproteinases in prostate cancer cells
    • Shin YJ, Kim JH. The role of EZH2 in the regulation of the activity of matrix metalloproteinases in prostate cancer cells. PLoS One 2012; 7: e30393.
    • (2012) PLoS One , vol.7
    • Shin, Y.J.1    Kim, J.H.2
  • 17
    • 80755144050 scopus 로고    scopus 로고
    • Overexpression of Fn14 promotes androgen-independent prostate cancer progression through MMP-9 and correlates with poor treatment outcome
    • Huang M, Narita S, Tsuchiya N, Ma Z, Numakura K, Obara T, Tsuruta H, Saito M, Inoue T, Horikawa Y et al. Overexpression of Fn14 promotes androgen-independent prostate cancer progression through MMP-9 and correlates with poor treatment outcome. Carcinogenesis 2011; 32: 1589-96.
    • (2011) Carcinogenesis , vol.32 , pp. 1589-1596
    • Huang, M.1    Narita, S.2    Tsuchiya, N.3    Ma, Z.4    Numakura, K.5    Obara, T.6    Tsuruta, H.7    Saito, M.8    Inoue, T.9    Horikawa, Y.10
  • 18
    • 80054678175 scopus 로고    scopus 로고
    • Oxidative stress and prostate cancer progression are elicited by membrane-type 1 matrix metalloproteinase
    • Nguyen HL, Zucker S, Zarrabi K, Kadam P, Schmidt C, Cao J. Oxidative stress and prostate cancer progression are elicited by membrane-type 1 matrix metalloproteinase. Mol Cancer Res 2011; 9: 1305-18.
    • (2011) Mol Cancer Res , vol.9 , pp. 1305-1318
    • Nguyen, H.L.1    Zucker, S.2    Zarrabi, K.3    Kadam, P.4    Schmidt, C.5    Cao, J.6
  • 21
    • 84860289206 scopus 로고    scopus 로고
    • ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion
    • Xiao LJ, Lin P, Lin F, Liu X, Qin W, Zou HF, Guo L, Liu W, Wang SJ, Yu XG. ADAM17 targets MMP-2 and MMP-9 via EGFR-MEK-ERK pathway activation to promote prostate cancer cell invasion. Int J Oncol 2012; 40: 1714-24.
    • (2012) Int J Oncol , vol.40 , pp. 1714-1724
    • Xiao, L.J.1    Lin, P.2    Lin, F.3    Liu, X.4    Qin, W.5    Zou, H.F.6    Guo, L.7    Liu, W.8    Wang, S.J.9    Yu, X.G.10
  • 22
    • 84896712359 scopus 로고    scopus 로고
    • Differential expression of matrix metalloproteinase-2 expression in disseminated tumor cells and micrometastasis in bone marrow of patients with nonmetastatic and metastatic prostate cancer: Theoretical considerations and clinical implications-an immunocytochemical study
    • Murray NP, Reyes E, Tapia P, Badinez L, Orellana N. Differential expression of matrix metalloproteinase-2 expression in disseminated tumor cells and micrometastasis in bone marrow of patients with nonmetastatic and metastatic prostate cancer: theoretical considerations and clinical implications-an immunocytochemical study. Bone Marrow Res 2012; 2012: 259351.
    • (2012) Bone Marrow Res , vol.2012 , pp. 259351
    • Murray, N.P.1    Reyes, E.2    Tapia, P.3    Badinez, L.4    Orellana, N.5
  • 23
    • 84887648334 scopus 로고    scopus 로고
    • Matrix metalloproteinases and cancer
    • Oncel M. Matrix metalloproteinases and cancer. Eur J Basic Med Sci 2012; 2: 91-100.
    • (2012) Eur J Basic Med Sci , vol.2 , pp. 91-100
    • Oncel, M.1
  • 24
    • 78851470329 scopus 로고    scopus 로고
    • Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancer
    • Park KS, Kim SJ, Kim KH, Kim JC. Clinical characteristics of TIMP2, MMP2, and MMP9 gene polymorphisms in colorectal cancer. J Gastroenterol Hepatol 2011; 26: 391-7.
    • (2011) J Gastroenterol Hepatol , vol.26 , pp. 391-397
    • Park, K.S.1    Kim, S.J.2    Kim, K.H.3    Kim, J.C.4
  • 27
    • 32644482152 scopus 로고    scopus 로고
    • The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer
    • O-Charoenrat P, Khantapura P. The role of genetic polymorphisms in the promoters of the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 genes in head and neck cancer. Oral Oncol 2006; 42: 257-67.
    • (2006) Oral Oncol , vol.42 , pp. 257-267
    • O-Charoenrat, P.1    Khantapura, P.2
  • 28
    • 74049148892 scopus 로고    scopus 로고
    • The association of MMP-9 enzyme activity, MMP- 9 C1562T polymorphism, and MMP-2 and -9 and TIMP-1, -2, -3, and -4 gene expression in lung cancer
    • Bayramoglu A, Gunes HV, Metintas M, Deǧirmenci I, Mutlu F, Alataş F. The association of MMP-9 enzyme activity, MMP- 9 C1562T polymorphism, and MMP-2 and -9 and TIMP-1, -2, -3, and -4 gene expression in lung cancer. Genet Test Mol Biomarkers 2009; 13: 671-8.
    • (2009) Genet Test Mol Biomarkers , vol.13 , pp. 671-678
    • Bayramoglu, A.1    Gunes, H.V.2    Metintas, M.3    Deǧirmenci, I.4    Mutlu, F.5    Alataş, F.6
  • 29
  • 30
    • 84863215648 scopus 로고    scopus 로고
    • Matrix metalloproteinase-2 promoter and tissue inhibitor of metalloproteinase-2 gene polymorphisms in non- Hodgkin's lymphoma
    • Diao LP, Ma H, Wei GC, Li T, Liu HS, Liu LH, Wu LL, Zhao GM, Gao YH. Matrix metalloproteinase-2 promoter and tissue inhibitor of metalloproteinase-2 gene polymorphisms in non- Hodgkin's lymphoma. Int J Cancer 2012; 131: 1095-103.
    • (2012) Int J Cancer , vol.131 , pp. 1095-1103
    • Diao, L.P.1    Ma, H.2    Wei, G.C.3    Li, T.4    Liu, H.S.5    Liu, L.H.6    Wu, L.L.7    Zhao, G.M.8    Gao, Y.H.9
  • 31
    • 84860606639 scopus 로고    scopus 로고
    • Association of promoter polymorphisms in MMP2 and TIMP2 with prostate cancer susceptibility in North India
    • Srivastava P, Lone TA, Kapoor R, Mittal RD. Association of promoter polymorphisms in MMP2 and TIMP2 with prostate cancer susceptibility in North India. Arch Med Res 2012; 43: 117-24.
    • (2012) Arch Med Res , vol.43 , pp. 117-124
    • Srivastava, P.1    Lone, T.A.2    Kapoor, R.3    Mittal, R.D.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.